SOD1 and Parkinson disease: Only Fernandes et al. (69) have reported that lutein treatment in a Drosophila PD model improved climbing ability and survival rate and restored brain dopamine levels, tyrosine hydroxylase activity, and SOD, catalase (CAT), and glutathione S-transferase (GST) levels, suggesting phenotypic improvement through antioxidant mechanisms.